ISPOR 15th Annual European Congress Disclosure Information for Research Presentations

Download ISPOR 15th Annual European Congress Disclosure Information for Research Presentations

Post on 30-Dec-2016

219 views

Category:

Documents

5 download

Embed Size (px)

TRANSCRIPT

  • ISPOR 15TH ANNUAL EUROPEAN CONGRESS DISCLOSURE INFORMATION FOR RESEARCH PRESENTATIONS

    The International Society for Pharmacoeconomics and Outcomes Research asked all abstract contributors to disclose financial support for their research.The following financial support was declared:

    ReferenceCode Financial Support

    ReferenceCode Financial Support

    CA1 French National Cancer Institute (INCa), Boulogne-Billancourt, FranceCA2 Costello Medical Consulting Ltd., Cambridge, UKCA3 NoneCA4 Bristol Myers-Squibb, Uxbridge, UKCL1 NoneCL2 Millennium, Boston, MA, USACL3 NoneCL4 PFIZER Italia S.R.L., Roma, ItalyCV1 British Heart Foundation, London, UKCV2 The Center for Translational Molecular Medicine, Eindhoven, NetherlandsCV3 Sorin Cardio Biomedica, Saluggia, ItalyCV4 Italian Ministry of Health, Rome, Italy; Regione Lombardia, Milan, ItalyDB1 NoneDB2 NovoNordisk, Warsaw, PolandDB3 Novartis Farmaceutica, Barcelona, SpainDB4 Novo Nordisk, Copenhagen, DenmarkDU1 NoneDU2 NoneDU3 H. Lundbeck A/S, Copenhagen, DenmarkDU4 Serbian Ministry of science, Belgrade, Serbia and MontenegroMA1 NoneMA2 UCB Pharma, Slough, UKMA3 JANSSEN-CILAG, SAO PAULO, BrazilMA4 Teva Pharmaceuticals, Horsham, PA, USAMO1 Lundbeck, Issy les Moulineaux, FranceMO2 GlaxoSmithKline, Zeist, NetherlandsMO3 COMET Center ONCOTYROL, Innsbruck, Austria; Tiroler Zukunftsstiftung/

    Standortagentur Tirol (SAT), Innsbruck, AustriaMO4 Pfizer UK, Tadworth, UKNI1 NoneNI2 Costello Medical Consulting Ltd, Cambridge, UKNI3 NoneNI4 NonePA1 Double Helix Consulting, London, UKPA2 Ministry of Health, rome, ItalyPA3 CEESTAHC, Krakow, PolandPA4 Baxter Healthcare Corporation, Braine lAlleud, BelgiumPCN1 Eisai, Inc, Woodcliff Lake, NJ, USAPCN2 Janssen-Cilag, Neuss, ME, GermanyPCN3 Amgen Inc., Thousand Oaks, CA, USAPCN4 FFG-sterreichische Forschungsfrderungsgesellschaft, Wien, AustriaPCN5 Sanofi Aventis Deutschland GmbH, Frankfurt, GermanyPCN6 Netherlands Organisation for Health Research and Development (ZonMw),

    Den Haag, Netherlands; Roche Nederland B.V., Woerden, Netherlands; PfizerB.V., Capelle aan den IJssel, Netherlands

    PCN7 Eli Lilly and Company, Indianapolis, IN, USAPCN8 Pfizer Global Pharmaceuticals, New York, NY, USAPCN9 Amgen Inc, Thousand Oaks, CA, USAPCN10 Eisai, Inc, Woodcliff Lake, NJ, USAPCN11 Celgene, Summit, NJ, USAPCN13 GlaxoSmithKline, Zeist, NetherlandsPCN14 NonePCN15 Agency for Health Technology Assessment In Poland (AHTAPol), Warsaw,

    PolandPCN16 Pfizer Poland, Warsaw, PolandPCN17 Roche Farmaceutica QUmica, Lda., Amadora, PortugalPCN19 NonePCN20 National Evidence-based Healthcare Collaborating Agency, Seoul, South

    KoreaPCN21 Bristol Myers Squibb, Sao Paulo, BrazilPCN22 NonePCN23 NonePCN24 Pfizer, New York, NY, USAPCN25 Roche, Moscow, RussiaPCN26 NonePCN27 Janssen-Cilag GmbH, Neuss, GermanyPCN28 NonePCN29 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPCN30 NonePCN31 NonePCN32 NonePCN33 NonePCN34 Lundbeck Canada, Montreal, QC, CanadaPCN35 Sanofi, Chilly Mazarin, France

    PCN36 Pliva Croatia Ltd., Zagreb, CroatiaPCN37 NonePCN38 United BioSource Corporation, Bethesda, MD, USAPCN39 Roche Products Limited, Welwyn Garden City, UKPCN40 NonePCN41 Nestle Health Science, Vevey, SwitzerlandPCN42 French National Cancer Institute (INCa), Boulogne-Billancourt, FrancePCN43 NonePCN44 Roche Austria, Vienna, AustriaPCN45 William Harvey Research Institute, London, UKPCN46 Janssen, Madrid, SpainPCN47 Deutsche Krebshilfe e. V., Bonn, GermanyPCN48 Sanofi Pasteur MSD, Maidenhead, UKPCN49 Brystol-Myers Squibb, Moscow, RussiaPCN50 Roche, Basel, SwitzerlandPCN51 Genentech, South San Francisco, CA, USAPCN52 Sanofi Pasteur MSD, Maidenhead, UKPCN53 NonePCN54 NonePCN55 NonePCN56 Sanofi Pasteur MSD, Maidenhead, UKPCN57 Janssen, the pharmaceutical division of Johnson & Johnson LLC, Moscow,

    Russia; Ferring Pharmaceuticals, LLC, Moscow, RussiaPCN58 The research is supported by the German Federal Ministry of Education and

    Research (BMBF), project grant No. 01EX1013B as part of the Centre ofExcellence for Medical Technology, Bonn, Germany

    PCN59 Novartis Pharma AG, Basel, SwitzerlandPCN60 NonePCN61 Bristol Myers Squibb, Sao Paulo, BrazilPCN62 Caris Life Sciences, Irving, TX, USAPCN63 Bristol-Myers Squibb, Madrid, SpainPCN64 Novartis Biociencias SA, Sao Paulo, BrazilPCN65 Expanded Program on Immunization, Colombian Ministry of Health and Social

    Protection, Bogota, ColombiaPCN66 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPCN67 NonePCN68 ZONMW, Den Haag, Netherlands; Roche B.V., Woerden, NetherlandsPCN69 NonePCN70 Ferring International Center SA , Saint-Prex, SwitzerlandPCN71 NonePCN72 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPCN73 Pfizer S.A. de C.V., Mexico City, MexicoPCN74 Baxter Healthcare SA, Zurich, SwitzerlandPCN75 Pfizer AB, Stockholm, SwedenPCN76 Roche Farma S.A., Madrid, SpainPCN77 NonePCN78 Sanofi Espana, Barcelona, SpainPCN79 elgene, Moscow, RussiaPCN80 Bristol Mysers-Squibb, Uxbridge, UKPCN81 GlaxoSmithKline, Uxbridge, UKPCN82 Roche Farma S.A., Madrid, SpainPCN83 NonePCN84 Janssen Cilag Pharmaceutical SACI, Athens, GreecePCN85 NonePCN86 JANSSEN-CILAG, SAO PAULO, BrazilPCN87 Roche, Mexico City, MexicoPCN88 NonePCN89 Abbott Laboratories, Abbott Park, IL, USAPCN90 Mundipharma, Hoevelaken, NetherlandsPCN91 Roche Farmaceutica Quimica, Amadora, PortugalPCN92 Novartis, Moscow, RussiaPCN93 Pfizer Poland, Warsaw, PolandPCN94 IMS Health , Alexandria , VA, USAPCN95 Roche Products Pty Ltd., Dee Why, AustraliaPCN96 Roche Hong Kong, Hong Kong, Hong KongPCN97 NonePCN98 Novartis Pharma AG, Basel, SwitzerlandPCN99 Amgen GmbH, Zug, SwitzerlandPCN100 Janssen-Cilag Ltd., Buckinghamshire, UKPCN101 NonePCN102 Bayer Healthcare Pharmaceuticals, Inc., Wayne, NJ, USAPCN103 NonePCN104 Roche Brazil, Sao Paulo, BrazilPCN105 Genentech Inc, San Francisco, CA, USA

    A576 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) A 5 7 6 - A 5 8 6

    Copyright 2012, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.

  • PCN106 NonePCN107 Pfizer GmbH, Berlin, GermanyPCN108 Eisai, Woodcliff Lake, NJ, USAPCN109 FFG-sterreichische Forschungsfrderungsgesellschaft, Wien, AustriaPCN110 Canadian Cancer Society Research Institute, Toronto, ON, Canada; National

    Institute of Health, Bethesda, MD, USAPCN111 Ontario Institute for Cancer Research, Toronto, ON, CanadaPCN112 NonePCN113 Genentech, South San Francisco, CA, USAPCN114 Millennium Pharmaceuticals, Inc, Cambridge, MA, USAPCN115 NonePCN116 Janssen Pharmaceutica N.V., Beerse, BelgiumPCN117 Fresenius Biotech GmbH, Munchen, GermanyPCN118 Amgen (Europe) GmbH, Zug, SwitzerlandPCN119 NonePCN120 Janssen Pharmaceutica, Beerse, BelgiumPCN121 Janssen Pharmaceutica N.V., Beerse, BelgiumPCN122 Amgen, Thousand Oaks, CA, USAPCN123 Genentech, Inc., South San Francisco, CA, USAPCN124 National Science Centre, Cracov, PolandPCN125 National Science Centre, Cracov, PolandPCN126 ZONMW, Den Haag, Netherlands; Janssen, Tilburg, NetherlandsPCN127 Health Care Insurance Board, Diemen, NetherlandsPCN128 NonePCN129 NonePCN130 NonePCN131 NonePCN132 Astrazeneca, Luton, UKPCN133 NonePCN134 NonePCN135 IMS Health, PARIS, FrancePCN136 Novartis Pharmaceuticals Canada, Dorval, QC, CanadaPCN137 IMS Health, London, UKPCN138 Sanofi, Bridgewater, NJ, USAPCN139 Ipsen Pharma SAS, Boulogne-Billancourt, FrancePCN140 Janssen Pharmaceutica, Beerse, BelgiumPCN141 Amgen BV, Breda, NetherlandsPCN142 NonePCN143 Sanofi, Guildford, UKPCN144 Costello Medical Consulting Ltd, Cambridge, UKPCN145 NonePCN146 NonePCN147 NonePCN148 Eli Lilly and Company, Indianapolis, IN, USAPCN149 Astellas Pharma Global Development, Leiderdorp, NetherlandsPCN150 NonePCN151 NonePCN152 German Association of Research-based Pharmaceutical Companies (vfa),

    Berlin, GermanyPCN153 Oncotyrol, Innsbruck, AustriaPCN154 NonePCN155 NonePCN156 NonePCN157 NonePCN158 Cancer Care Ontario, Toronto, ON, Canada; Ontario Ministry of Health &

    Long Term Care, Toronto, ON, Canada; Ontario Institute for CancerResearch, Toronto, ON, Canada

    PCN159 Bristol Myers Squibb, Sao Paulo, BrazilPCV1 NonePCV2 NonePCV3 Merck, Whitehouse Station, NJ, USAPCV4 St.Lukes Life Science Institute, Tokyo, JapanPCV5 NonePCV6 NonePCV7 National Institute for Health Research, Southampton, UKPCV8 Eli Lilly and Company, Indianapolis, IN, USA; Daiichi Sankyo Company,

    Limited, Parsippany, NJ, USAPCV9 NonePCV10 NonePCV11 The Health Council of The Netherlands, The Hague, NetherlandsPCV12 Novartis Pharma AG, Basel, SwitzerlandPCV13 LA-SER Europe Ltd., London, UKPCV14 Daiichi Sankyo, Parsippany, NJ, USAPCV15 Bristol-Myers Squibb, Rueil-Malmaison, FrancePCV16 NonePCV17 Bristol-Myers Squibb, Rueil-Malmaison, FrancePCV18 NonePCV19 NonePCV20 NonePCV21 NonePCV22 None

    PCV23 NonePCV24 BERLIN-CHEMIE, Moscow, RussiaPCV25 Eli Lilly and Company, Indianapolis, IN, USA; Daiichi Sankyo Company,

    Limited , Parsippany, NJ, USAPCV26 AstraZeneca Pharmaceuticals, Moscow, RussiaPCV27 NonePCV28 Bristol-Myers Squibb, Rueil-Malmaison, France; Pfizer, Paris, FrancePCV29 Pfizer, Alcobendas, SpainPCV30 Abbott Vascular, Diegem, BelgiumPCV31 Ministry of Science and Environmental Protection of the Republic of Serbia ,

    Belgrade, Serbia and MontenegroPCV32 NonePCV33 NonePCV34 Eli Lillly Company Turkey, Istanbul, TurkeyPCV35 Amgen, Munchen, GermanyPCV36 Actavis Deutschland GmbH & Co. KG , Munchen, GermanyPCV37 Bristol Myers Squibb, Sao Paulo, BrazilPCV38 The Medicines Company, Parsippany, NJ, USAPCV39 Pfizer, Mexico, Mexico; Bristol-Myers Squibb, Mexico, MexicoPCV40 NonePCV41 Bayer HealthCare, Moscow, RussiaPCV42 Bayer HealthCare, Moscow, RussiaPCV43 NonePCV44 Novartis, Hellas, GreecePCV45 AstraZeneca Turkey, Istanbul, TurkeyPCV46 Bayer HealthCare Pharmaceuticals, Moscow, RussiaPCV47 The Health Council of The Netherlands, The Hague, NetherlandsPCV48 Janssen Pharmaceuticals, Inc., Raritan, NJ, USAPCV4

Recommended

View more >